Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04998669
Title Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Juan P. Alderuccio, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists and Research Institute NOT_YET_RECRUITING Fort Myers Florida 33916 United States Details
University of Miami RECRUITING Miami Florida 33136 United States Details
University of Michigan NOT_YET_RECRUITING Ann Arbor Michigan 48109 United States Details
Rutgers Cancer Institute of New Jersey NOT_YET_RECRUITING New Brunswick New Jersey 08901 United States Details
Allegheny Health Network NOT_YET_RECRUITING Pittsburgh Pennsylvania 15212 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field